Down-regulation of adenosine A(2A) receptors upon NGF-induced differentiation of PC 12 cells

Neuropharmacology

Volumn 36, Issue 9, 1997, Pages 1319-1326

  Arslan, Giulia ^a   Kontny, Ewa ^b   Fredholm, Bertil B ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b INSTITUTE OF RHEUMATOLOGY   (Poland)

Author keywords

A(2A) receptor; MAP kinase; NGF; PC12 cells

Indexed keywords

ADENOSINE A2 RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; NERVE GROWTH FACTOR; NEUROTROPHIN;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; DOWN REGULATION; ENZYME ACTIVATION; NERVE CELL DIFFERENTIATION; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

EID: 0030694507     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(97)00090-7     Document Type: Review

References (39)

1. Abbracchio M. P., Cattabeni F., Clementi F. and Sher E. (1989) Adenosine receptors linked to adenylate cyclase activity in human neuroblastoma cells: modulation during cell differentiation. Neuroscience 30: 819-825.
2. Andreopoulos S., Li P. P. and Warsh J. J. (1995) Developmental expression of G alpha o and G alpha s isoforms in PC12 cells: relationship to neurite outgrowth. Brain Research. Developmental Brain Research 88: 30-36.
3. 3H]-SCH 58261 to coronary artery membranes. Circulation Research 79: 1153-1160.
4. ras-directed activation of extracellular signal-related kinase 2 and phosphorylation of mSos nucleotide exchange factor. EMBO Journal 12: 4211-4220.
5. 2A adenosine receptor-mediated cyclic AMP response: role for protein phosphatase 2A. Molecular Pharmacology 48: 1-8.
6. 2a adenosine receptor-mediated cAMP elevation in rat pheochromocytoma PC12 cells. Molecular Pharmacology 44: 950-958.
7. 2a adenosine receptor gene. DNA Cell Biology 15: 329-337.
8. Clementi E., Racchetti G., Zacchetti D., Panzeri M. C. and Meldolesi J. (1992) Differential expression of markers and activities in a group of PC12 nerve cell clones. European Journal of Neuroscience 4: 944-953.
9. Cowley S., Paterson H., Kemp P. and Marshall C. J. (1994) Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 77: 841-852.
10. Damon D. H., D'Amore P. A. and Wagner J. A. (1990) Nerve growth factor and fibroblast growth factor regulate neunte outgrowth and gene expression in PC12 cells via both protein kinase C-and cAMP-independent mechanisms. Journal of Cell Biology 110: 1333.
11. Erhardt P., Troppmair J., Rapp U. R. and Cooper G. M. (1995) Differential regulation of Raf-1 and B-Raf and Ras-dependent activation of mitogen-activated protein kinase by cyclic AMP in PC12 cells. Molecular and Cellular Biology 15: 5524-5530.
12. Fredholm B. B. (1995) Purinoceptors in the nervous system. Pharmacology and Toxicology 76: 228-239.
13. Fredholm B. B., Abbracchio M. P., Burnstock G., Daly J. W., Harden T. K., Jacobson K. A., Leff P. and Williams M. (1994) Nomenclature and classification of purinoceptors. Pharmacological Reviews 46: 143-156.
14. Frödin M., Peraldi P. and Van Obberghen E. (1994) Cyclic AMP activates the mitogen-activated protein kinase cascade in PC12 cells. Journal of Biological Chemistry 269: 6207-6214.
15. Ginty D. D., Glowacka D., DeFranco C. and Wagner J. A. (1991) Nerve growth factor-induced neuronal differentiation after dominant repression of both type I and type II cAMP-dependent protein kinase activities. Journal of Biological Chemistry 266: 15325-15333.
16. Graves L. M., Bornfeldt K. E., Raines E. W., Potts B. C., Macdonald S. G., Ross R. and Krebs E. G. (1993) Protein kinase A antagonizes platelet-derived growth factor-induced signaling by mitogen-activated protein kinase in human arterial smooth muscle cells. Proceedings of the National Academy of Science of the U.S.A. 90: 10300-10304.
17. Greene L. A., Sobeih M. M. and Teng K. K. (1991) Methodologies for the culture and experimental use of the PC12 rat pheochromocytoma cell line. In: Culturing nerve cells (Banker G. and Goslin K.), pp. 178-212. MIT Press, Cambridge.
18. Greene L. A. and Tischler A. S. (1976) Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proceedings of the National Academy of Science of the U.S.A. 73: 2424-2428.
19. Gunning P. W., Landreth G. E., Bothwell M. A. and Shooter E. M. (1981) Differential and synergistic actions of nerve growth factor and cyclic AMP in PC12 cells. Journal of Cell Biology 89: 240-245.
20. Guroff G., Dickens G., End D. and Londos C. (1981) The action of adenosine analogues on PC 12 cells. Journal of Neurochemistry 37: 1431-1439.
21. 2A adenosine receptors from rat striatum and rat pheochromocytoma PC12 cells: characterization with radioligand binding and by activation of adenylate cyclase. Molecular Pharmacology 41: 352-359.
22. Hordijk P. L., Verlaan I., van Corven E. J. and Moolenaar W. H. (1994) Protein tyrosine phosphorylation induced by lysophosphatidic acid in Rat-1 fibroblasts. Evidence that phosphorylation of map kinase is mediated by the Gi-p21ras pathway. Journal of Biological Chemistry 269: 645-651.
23. Kenakin T. (1993) In: Pharmacologic analysis of drug-receptor interaction, 2nd Edn. Raven Press, New York.
24. Kim K.-S., Ishiguro H., Tinti C., Wagner J. and Joh T. H. (1994) The cAMP-dependent protein kinase regulates transcription of the dopamine beta-hydroxylase gene. Journal of Neuroscience 14: 7200-7207.
25. LNGFR and AP-1 transcription factor and in PC12 cell differentiation induced by nerve growth factor. Journal of Molecular Neuroscience 8: 29-44.
26. 2A receptors. Pharmacology and Toxicology 76 (II): P1.26.
27. McMahon A. and Sabban E. L. (1992) Regulation of expression of dopamine beta-hydroxylase in PC12 cells by glucocorticoids and cyclic AMP analogues. Journal of Neurochemistry 59: 2040-2047.
28. Nordstedt C. and Fredholm B. B. (1990) A modification of a protein-binding method for rapid quantification of cAMP in cell-culture supernatants and body fluid. Analytical Biochemistry 189: 231-234.
29. Noronha-Blob L., Marshall R. P., Kinnier W. J. and U'Prichard D. C. (1986) Pharmacological profile of adenosine A2 receptor in PC12 cells. Life Science 39: 1059-1067.
30. 2A receptors. Trends in Pharmacological Sciences 17: 364-372.
31. 2A receptors in Jurkat cells and PC12 cells using adenosine receptor agonists. Naunyn-Schmiedeberg's Archives of Pharmacology 353: 250-260.
32. 1 dopamine receptor. Brain Research 519: 333-337.
33. 3H]-adenosine, a tracer for neuronal connectivity. Brain Research 85: 317-319.
34. Sevetson B. R., Kong X. and Lawrence J. C. Jr (1993) Increasing cAMP attenuates activation of mitogen-activated protein kinase. Proceedings of the National Academy of Science of the U.S.A. 90: 10305-10309.
35. Shafer T. J. and Atchison W. D. (1991) Transmitter, ion channel and receptor properties of pheochromocytoma (PC12) cells: a model for neurotoxicological studies. Neurotoxicology 12: 473-492.
36. Sithanandam G., Kolch W., Duh F. M. and Rapp U. R. (1990) Complete coding sequence of a human B-raf cDNA and detection of B-raf protein kinase with isozyme specific antibodies. [Review]. Oncogene 5: 1775-1780.
37. Storm S. M., Cleveland J. L. and Rapp U. R. (1990) Expression of raf family proto-oncogenes in normal mouse tissues. Oncogene 5: 345-351.
38. Young S. W., Dickens M. and Tavaré J. M. (1994) Differentiation of PC12 cells in response to a cAMP analogue is accompanied by sustained activation of mitogen-activated protein kinase. Comparison with the effects of insulin, growth factors and phorbol esters. FEBS Letters 338: 212-216.
39. 2A adenosine receptor antagonist. Journal of Pharmacology and Experimental Therapeutics 276: 398-404.